Revised List of Pharma Patents - Controller General of Patents ...

More documents

Recommendations

Info

2782 3387/CHENP/2005 232234 16-03-2009 DRUG CONJUGATE COMPOSITION IMMUNOGEN, INC2783 2071/CHENP/2006 232248 16-03-2009SUBSTITUTED 1H-PYRROLO[3,2-B, 3,2-C, AND2,3-C]PYRIDINE-2-CARBOXAMIDES ANDRELATED ANALOGS AS INHIBITORS OFAVENTIS PHARMACEUTICALS, INCCASEIN KINASE I EPSILON2784 1778/CHENP/2006 232271 16-03-20092-HYDROXY-3-N-HETEROCYCLYLALKYL-AMINO-PROPYL-PHOSPHINIC ACIDSNOVARTIS AG2785 2098/CHENP/2006 232272 16-03-2009SOLID DISPERSIONS OR SOLIDDISPERSION PHARMACEUTICALPREPARATIONS OF PHENYLALANINEAJINOMOTO CO., INCDERIVATIVES2786 34/MUMNP/2006 232287 16/3/2009FUSED COMPOUNDS THAT INHIBITVANILLOID RECEPTOR SUBTYPE 1 (VR1)ABBOTT LABORATORIES2787 2387/CHENP/2005 232293 16-03-2009SYNTHESIS OF 2-CHLOROMETHYL-6-METHYLBENZOIC ACID ESTERSSANOFI-AVENTIS DEUTSCHLAND GmbH2788 IN/PCT/2002/00773/MUM 232300 16/3/2009 A PHOSPHONIC DIAMIDE OF FORMULA IA METABASIS THERAPEUTICS, INC.2789 2226/CHENP/2005 232301 16-03-2009A SUBSTITUTED PIPERIDINES AS MDM2-p53INHIBITORSF. HOFFMANN-LA ROCHE AG2790 3476/CHENP/2005 232303 16-03-2009AN ANTIBODY OR ANTIGEN-BINDINGPORTION THEREOF WHICH BINDS TO MEDAREX, INCBACILLUS ANTHRACIS PROTECTIVE ANTIGEN2791 937/MUMNP/2005 232328 16/3/2009MODIFIED TERT PROMOTER WITH ENHANCEDINDUSTRY-ACADEMIC COOPERATIONTUMOR-SPECIFICITY AND STRENGTH ANDFOUNDATION YONSEI UNIVERSITY,KIM, JOO-RECOMBINANT VECTOR COMPRISING THEHANGSAME2792 395/MUMNP/2006 232350 16/3/2009 NOVEL HYPOCHOLESTEROLEMIC LIPIDEON BIOTECHNOLOGY AGINDAZOLE COMPOUNDS AND2793 IN/PCT/2001/01148/DEL 232353 16-03-2009PHARMACEUTICAL COMPOSITIONS FORAGOURON PHARAMACEUTICALS, INC.INHIBITING PROTEIN KINASES, AND METHODSFOR THEIR USE"NOVEL SUBSTITUTED 3-CYANOTHIOPHENE2794 4711/DELNP/2005 232354 17-10-2005 ACETAMIDES AS GLUCAGON RECEPTOR F. HOFFMANN-LA ROCHE AGANTAGONISTS OF GENERAL FORMULA (I)"2795 238/MUMNP/2006 232444 16/3/2009FUSED AZABICYCLIC COMPOUNDS THATINHIBIT VANILLOID SUBTYPE 1 (VR1)ABBOTT LABORATORIESACYLATED AND NON-ACYLATED IMIDAZO[2,1-2796 2571/KOLNP/2005 232527 18-03-2009 B]-1,3,4,-THIADIAZOLE-2-SULFONAMIDES, AND AEGERA THERAPEUT CS INC.USES THERE OF
2797 2043/CHENP/2005 232652 20-03-20092798 60/DELNP/2006 232730 20-03-20092799 1361/DEL/1999 232860 21-03-20092800 298/KOLNP/2003 233032 25-03-20092801 90/KOL/2005 233040 25-03-20092802 00471/DELNP/2004 233057 25-03-20092803 53/DELNP/2006 233092 26-03-20092804 1132/DEL/2001 233125 26-03-20092805 1721/DELNP/2004 233155 27-03-20092806 IN/PCT/2002/01168/DEL 233235 27-03-20092807 01131/DELNP/2003 233340 28-03-20092808 IN/PCT/2002/00945/DEL 233341 28-03-20092809 00961/DELNP/2003 233345 28-03-20092810 92/DELNP/2006 233424 30-03-20092811 2090/DELNP/2004 233569 30-03-20093-METHYL-2 (3-(2-PHENYL-OXAZOL-4-YLMETHOXY)-CYCLOHEXANECARBONYL-AMINOBUTYRIC ACID DERIVATIVES ANDSANOFI-AVENTIS DEUTSCHLAND GmbHRELATED COMPOUNDS AS PPARMODULATORS FOR THE TREATMENT OFTYPE 2 DIABETES ANDATHEROSCLEROSISA MORPHOLINOMETHYL-BENZIMIDAZOL-2-YLPYRAZOLE COMPOUND OF THEASTEX THERAPEUTICS LIMITEDFORMULA(VII)A PHARMACEUTICAL COMPOSITIONPFIZER PRODUCTS INC.CONTAINING SERTRALINEIMMUNOGENIC COMPOSTION FOR INDUCINGTHE AUSTIN RESEARCH INSTITUTEIMMUNE RESPONSE IN A SUBJECTNOVEL ORALLY ADMINISTRABLE ANTI-DIABETIC COMPOUNDS, PROCESS FORBIRLA INSTITUTE OF TECHNOLOGYPRODUCING THEM AND THERAPEUTICCOMPOSITIONS CONTAINING THE SAME .SUBSTITUTED DIHYDROPTERIDINONE OF BOEHRINGER INGELHEIM PHARMA GMBH &GENERAL FORMULA (I)CO. KG.A PYRROLO(3,4-C) PYRAZOLE COMPOUND OFPFIZER ITALIA S.R.LFORMULA(I)CONTROLLED-RELEASE MICROGRANULES LABORATOIRES DES PRODUITS ETHIQUESCONTAINING CISPLATINETHYPHARMALPHA-[N-SULFONAMIDO]ACETAMIDEBRISTOL-MYERS SQUIBB COMPANYDERIVATIVES AS BETA-AMYLOID INHIBITORSA RADIOPHARAMACEUTICAL COMPOUND OFBRISTOL-MYERS SQUIBB PHARMA COMPANYFORMULA (I)A PHENYLAMINE COMPOUND HAVING PDE4MEMORY PHARMACEUTICALS CORPORATIONINBIBITOR ACTIVITYOLIGOSACCHARIDES OF FORMULA (I) HAVINGAVENTIS PHARMA S.A.ANTI-INFLAMMATORY PROPERTIESNOVEL QUINUCLIDINE DERIVATIVES ANDMEDICINAL COMPOSITIONS CONTAINING THE ALMIRALL AG.,SAMEPYRIMIDINE-2,4-DIONE AS GONADOTROPINRELEASING HORMONE RECEPTORNEUROCRINE BIOSCIENCES, INC.ANTAGONSTSPHARMACEUTICAL COMPOSITIONGALDERMA RESEARCH & DEVELOPMENT,COMPRISING AR LEAST A RETINOID ANDS.N.CBENZOYL PEROXIDE
Page 1:
Product Patents in Pharmaceuticals
Page 4 and 5:
65 IN/PCT/2001/1516/CHE 202356 09-1
Page 6 and 7:
99 IN/PCT/2000/664/MUM 203095 27/10
Page 8 and 9:
136 810/BOM/1999 204043 27/02/2007
Page 10 and 11:
173 IN/PCT/2001/503/MUM 204672 01-0
Page 12 and 13:
219 1079/CHENP/2004 205676 09-04-20
Page 14 and 15:
258 IN/PCT/2002/1868/MUM 206233 19/
Page 16 and 17:
303 2609/MAS/1998 206960 16-05-2007
Page 18 and 19:
340 333/MUMNP/2005 207881 29/06/200
Page 20 and 21:
380 782/MUM/2004 208592 02-08-2007A
Page 22 and 23:
417 IN/PCT/2002/1605/CHE 208917 16-
Page 24 and 25:
454 195/MUMNP/2005 209147 21/08/200
Page 26 and 27:
491 574/DEL/2001 209451 30-08-2007H
Page 28 and 29:
538 194/DEL/2004 209857 07-09-2007A
Page 30 and 31:
577 3207/DEL/2005 210329 28-09-2007
Page 32 and 33:
A PHARMACEUTICAL PRODUCT FORCOUNTER
Page 34 and 35:
653 382/MUMNP/2005 211375 26/10/200
Page 36 and 37:
688 452/CHENP/2003 211580 05-11-200
Page 38 and 39:
730 99/CHENP/2004 211840 13-11-2007
Page 40 and 41:
767 1151/CHENP/2003 212206 26-11-20
Page 42 and 43:
800 IN/PCT/2001/33/KOL 212615 04-12
Page 44 and 45:
842 1329/CHENP/2003 213069 19-12-20
Page 46 and 47:
881 119/MUMNP/2005 213311 27-12-200
Page 48 and 49:
922 IN/PCT/2002/1444/MUM 213842 21/
Page 50 and 51:
961 614/MUMNP/2003 214197 07-02-200
Page 52 and 53:
HERBAL COMPOSITION FOR THE TREATMEN
Page 54 and 55:
1031 1535/KOLNP/2004 215531 27-02-2
Page 56 and 57:
1073 37/DEL/2000 216398 12-03-2008L
Page 58 and 59:
1110 IN/PCT/2000/668/KOL 216904 19-
Page 60 and 61:
1148 2521/DELNP/2004 217950 31-03-2
Page 62 and 63:
1186 119/MUM/2004 218479 02-04-2008
Page 64 and 65:
1228 IN/PCT/2001/01235/MUM 218742 1
Page 66 and 67:
1264 811/MUM/2004 219014 16/04/2008
Page 68:
1306 721/MAS/1996 219271 28-04-2008
Page 71 and 72:
RECOMBINANT NUCLEIC ACID MOLECULES1
Page 73 and 74:
1401 2945/DELNP/2005 220218 19-05-2
Page 75 and 76:
1440 713/DEL/2002 220683 02-06-2008
Page 77 and 78:
1481 305/DEL/2002 221053 13-06-2008
Page 79 and 80:
1521 IN/PCT/2002/162/CHE 221395 23-
Page 81 and 82:
AN AYURVEDIC COMPOSITION FOR ORAL15
Page 83 and 84:
1,2,3-TRISUBSTITUTED ARYL ANDHETERO
Page 85 and 86:
1631 IN/PCT/2002/345/CHE 222560 14-
Page 87 and 88:
1670 773/MUMNP/2003 222823 25/08/20
Page 89 and 90:
1709 IN/PCT/2002/00850/DEL 223094 0
Page 91 and 92:
1743 1811/CHENP/2004 223246 09-09-2
Page 93 and 94:
1779 IN/PCT/2001/1002/CHE 223544 12
Page 95 and 96: 1814 2844/DEL/1996 223754 23-09-200
Page 97 and 98: 1852 00822/DELNP/2003 224186 01-10-
Page 99 and 100: 1890 2694/DELNP/2004 224371 13-10-2
Page 101 and 102: 1927 2684/DEL/1997 224571 17-10-200
Page 103 and 104: 1961 3275/DELNP/2005 224809 22-10-2
Page 105 and 106: 1997 3330/DELNP/2004 225015 29-10-2
Page 107 and 108: 2032 IN/PCT/2001/9/KOL 225227 05-11
Page 109 and 110: 2068 434/KOLNP/2005 225441 12-11-20
Page 111 and 112: 1,2,4-OXADIAZOLE DERIVATIVES AS HPP
Page 113 and 114: 2147 668/MUM/2002 225930 03-12-2008
Page 115 and 116: 2186 967/MAS/1997 226322 17-12-2008
Page 117 and 118: 2220 1029/KOLNP/2004 226708 24-12-2
Page 119 and 120: 2253 351/CHENP/2004 227043 31-12-20
Page 121 and 122: 2293 1355/MAS/1996 227418 07-01-200
Page 123 and 124: FARNESYL DIBENZODIAZEPINONES,2328 1
Page 125 and 126: 2367 910/CHENP/2004 227963 27-01-20
Page 127 and 128: 2406 2262/CHENP/2005 228171 28-01-2
Page 129 and 130: 2449 1660/KOLNP/2005 228778 10-02-2
Page 131 and 132: 2490 1538/CHENP/2004 229051 13-02-2
Page 133 and 134: 2527 842/CHENP/2004 229276 16-02-20
Page 135 and 136: 2-ALKYNYL-AND-2-ALKENYL-PYRAZOLO-[4
Page 137 and 138: 2605 1557/CHENP/2003 229915 24-02-2
Page 139 and 140: 2641 664/MUM/2001 230188 25/2/2009B
Page 141 and 142: 2684 650/CHENP/2004 230522 27-02-20
Page 143 and 144: 2723 2376/CHENP/2005 231260 04-03-2
Page 145: 2760 3714/DELNP/2005 231497 05-03-2
Page 149 and 150: 2833 800/CHENP/2005 233747 02-04-20
Page 151 and 152: A RECOMBINANT NUCLEIC ACID MOLECULE
Page 153 and 154: NOVEL 4, 10ß-DIACETOXY-2A-BENZOYLO
Page 155 and 156: 2950 1015/MUMNP/2006 234427 28/5/20
Page 157 and 158: 2984 5989/DELNP/2005 234665 10-06-2
Page 159 and 160: 3022 1586/DEL/2004 235036 24-06-200
Page 161 and 162: 3059 5604/DELNP/2006 235498 06-07-2
Page 163 and 164: 3098 262/KOL/2006 235813 02-09-2009
Page 165 and 166: 3133 720/DELNP/2005 236122 29-09-20
Page 167 and 168: 3165 70/KOLNP/2005 236431 29-10-200
Page 169 and 170: 3197 391/DELNP/2003 236723 17-11-20
Page 171 and 172: 3233 21/CHENP/2006 237090 04-12-200
Page 173 and 174: 3275 4817/CHENP/2006 237397 18-12-2
Page 175 and 176: 3310 1389/MUMNP/2005 237747 18/12/2
Page 177 and 178: 3346 3616/CHENP/2006 238025 18-01-2
Page 179 and 180: 3385 01436/DELNP/2003 238542 10-02-
Page 181 and 182: 3418 787/KOLNP/2004 238836 24-02-20
Page 183 and 184: 3452 4627/DELNP/2005 239487 23-03-2
Page 185: * N.B.- Twenty- year term of patent
show all

Revised List of Pharma Patents - Controller General of Patents ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?